Karen Harvey v. HHS - Tdap, radiculoplexus neuropathy (2020)

Filed 2018-02-01Decided 2020-11-12Vaccine Tdap
compensated$50,000

Case summary [AI summaries can sometimes make mistakes]

Karen Harvey filed a petition on February 1, 2018, alleging that a Tdap vaccine administered on August 18, 2016, caused her to suffer from radiculoplexus neuropathy. The respondent denied that the vaccine caused the alleged injury or any other injury, and denied that petitioner's condition was a sequelae of a vaccine-related injury.

Despite these denials, the parties reached a stipulation for compensation. Special Master Nora Beth Dorsey reviewed the stipulation and found it reasonable, adopting it as the decision of the Court.

The stipulation awarded Karen Harvey a lump sum of $50,000.00, representing compensation for all damages available under 42 U.S.C. § 300aa-15(a). The decision was based on this stipulation and judgment was to be entered accordingly.

Petitioner was represented by Maximillian J. Muller of Muller Brazil, LLP, and respondent was represented by Julia Collison of the U.S.

Department of Justice. The decision was issued on November 12, 2020.

Theory of causation

Petitioner Karen Harvey alleged that a Tdap vaccine administered on August 18, 2016, caused her to suffer from radiculoplexus neuropathy. Respondent denied causation. The parties reached a stipulation for compensation, which was adopted by Special Master Nora Beth Dorsey. The stipulation awarded petitioner a lump sum of $50,000.00. The public decision does not describe the specific theory of causation, medical experts, onset, symptoms, tests, treatments, or mechanism of injury. The case was resolved via stipulation, not litigation on the merits of causation.

Source PDFs 2 total · 1 downloaded